Refining the role of BRCA1 in combating oxidative stress

Por Marks, Jeffrey R
Publicado em 2013

Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia

Por Kung, Hsiu-Ni, Marks, Jeffrey R., Chi, Jen-Tsan
Publicado em 2011

The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy

Por Wardell, Suzanne E., Marks, Jeffrey R., McDonnell, Donald P.
Publicado em 2011

Oxidatively Modified Proteins as Plasma Biomarkers in Breast Cancer

Por Jin, Hongjun, Daly, Don S., Marks, Jeffrey R., Zangar, Richard C.
Publicado em 2013

Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients

Por Liggett, Thomas E., Melnikov, Anatoliy A., Marks, Jeffrey R., Levenson, Victor V.
Publicado em 2010

Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES is Consistently Increased

Por Gonzalez, Rachel M, Daly, Don S, Tan, Ruimin, Marks, Jeffrey R, Zangar, Richard C
Publicado em 2011

High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer

Por Huang, Zhiqing, Wen, Yaqing, Shandilya, Ruby, Marks, Jeffrey R., Berchuck, Andrew, Murphy, Susan K.
Publicado em 2006

A joint analysis of metabolomics and genetics of breast cancer

Por Tang, Xiaohu, Lin, Chao-Chieh, Spasojevic, Ivan, Iversen, Edwin S, Chi, Jen-Tsan, Marks, Jeffrey R
Publicado em 2014

Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis

Por Ryser, Marc D., Worni, Mathias, Turner, Elizabeth L., Marks, Jeffrey R., Durrett, Rick, Hwang, E. Shelley
Publicado no J Natl Cancer Inst (2015)

Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy

Por Horne, Hisani N., Lee, Paula S., Murphy, Susan K., Alonso, Miguel A., Olson, John A., Marks, Jeffrey R.
Publicado em 2009

Loss of ARID1A-associated Protein Expression Is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers

Por Lowery, William J., Schildkraut, Joellen M., Akushevich, Liudmila, Bentley, Rex, Marks, Jeffrey R., Huntsman, David, Berchuck, Andrew
Publicado em 2012

Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors

Por Schildkraut, Joellen M., Iversen, Edwin S., Akushevich, Lucy, Whitaker, Regina, Bentley, Rex C., Berchuck, Andrew, Marks, Jeffrey R.
Publicado em 2013

Do serum biomarkers really measure breast cancer?

Por Yurkovetsky Zoya, Mukherjee Sayan, Jesneck Jonathan L, Clyde Merlise, Marks Jeffrey R, Lokshin Anna E, Lo Joseph Y
Publicado em 2009-05-01

Cell Cycle Progression in G(1) and S Phases Is CCR4 Dependent following Ionizing Radiation or Replication Stress in Saccharomyces cerevisiae

Por Westmoreland, Tammy J., Marks, Jeffrey R., Olson, John A., Thompson, Eric M., Resnick, Michael A., Bennett, Craig B.
Publicado em 2004

Do serum biomarkers really measure breast cancer?

Por Jesneck, Jonathan L, Mukherjee, Sayan, Yurkovetsky, Zoya, Clyde, Merlise, Marks, Jeffrey R, Lokshin, Anna E, Lo, Joseph Y
Publicado em 2009

Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes

Por Gatza, Michael L, Kung, Hsiu-Ni, Blackwell, Kimberly L, Dewhirst, Mark W, Marks, Jeffrey R, Chi, Jen-Tsan
Publicado em 2011

Regulation of the Metastasis Suppressor Gene MKK4 in Ovarian Cancer

Por Spillman, Monique A., Lacy, Judith, Murphy, Susan K., Whitaker, Regina S., Grace, Lisa, Teaberry, Vanessa, Marks, Jeffrey R., Berchuck, Andrew
Publicado em 2007

Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer

Por Nolen, Brian M, Marks, Jeffrey R, Ta'san, Shlomo, Rand, Alex, Luong, The Minh, Wang, Yun, Blackwell, Kimberly, Lokshin, Anna E
Publicado em 2008

Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues

Por Sfakianos, Gregory P., Iversen, Edwin S., Whitaker, Regina, Akushevich, Liudmila, Schildkraut, Joellen M., Murphy, Susan K., Marks, Jeffrey R., Berchuck, Andrew
Publicado em 2012

Severe Obesity Is Associated with Symptomatic Presentation, Higher Parathyroid Hormone Levels, and Increased Gland Weight in Primary Hyperparathyroidism

Por Adam, Mohamed Abdelgadir, Untch, Brian R., Danko, Melissa E., Stinnett, Sandra, Dixit, Darshana, Koh, James, Marks, Jeffrey R., Olson, John A.
Publicado em 2010